Dan Steele was in his early-40s, focused on a career as a civil servant, a role as a volunteer ski … Read More
Data-sharing may help advance personalized medicine therapies for Parkinson’s
For Dr. Davide Martino, who leads the Calgary Parkinson Research Initiative (CaPRI), patient involvement in research is vital. “They can … Read More
Research, clinical and other emerging trends in Parkinson’s meeting
On March 26 and 27, 2020, we are hosting a virtual meeting with leading Canadian researchers, clinicians and patients to … Read More
Julie Wysocki speaks at University of Manitoba Café Scientifique
Julie Wysocki, Director Research Program and Partnerships who leads Parkinson Canada’s National Research Program will be moderating UM’s Café Scientifique … Read More
COVID-19 and Parkinson’s
As the vaccine is rolling out in phases, several provinces have updated eligibility criteria for vaccine prioritization. While Parkinson’s may … Read More
CEO Dr. Karen Lee talks Parkinson Canada’s plans for 2021 on podcast
More than ever, we are here to listen to and support the Parkinson Community, no matter what. This is the … Read More
Living Well with Parkinson’s, Together: No Matter What
Thanks to the support of donors, volunteers and everyone who is part of the Parkinson Community, Parkinson Canada has been … Read More
BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND Clearance for DA01 in Parkinson’s Disease
BlueRock Therapeutics shared a news release on January 7, 2020 announcing the funding of a two-year trial using adult donor … Read More
Newly established Parkinson Advisory Council (PAC) prioritizes raising the voice of people affected by Parkinson’s
Raising the voice of people affected by Parkinson’s has always been an important priority of Parkinson Canada and was one … Read More
Limit of annual procedures in British Columbia for Duodopa therapy removed
We are pleased to share the BC Pharmacare announcement that Duodopa is now listed on formulary effective Dec. 10, 2020, … Read More







